262 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 262 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Tumor, Oncology, Cancer, Clinical, Cell, Therapeutic, Drug, Therapies, Solid-Tumors .

Start-ups (24)

Early-stage companies (73)

Established companies (147)

The majority of these companies is located in the following countries.

United States (154)

China (19)

United Kingdom (14)

Germany (11)

Example Companies

Find companies in your area

Kiromic Biopharma

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

immunotherapies for orphan inherited blood diseases, hematological cancers, and solid tumors. For more information, visit - Technology - Clinical Program - Pipeline

AIDT-1 (Hematologic Indications) Pre-clinical PD-1 Check Point Inhibitor (Solid Tumors) Pre-clinical Last Updated: 5/6/2020 EOC MPM Hematology R&D Strategy

Kura Oncology Kura Oncology, Inc.

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

are advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers. Our differentiated pipeline programs consist of small ...

cutaneous and lung. Preclinical and clinical data suggest that, among solid tumors with HRAS mutations, squamous cell tumors are sensitive tumors to treatment ...

(PTCL) In addition to our tipifarnib development program in HRAS mutant solid tumors, we are evaluating the potential utility of tipifarnib using CXCL12 pathway ...

expression is known to be a poor prognosis factor in patients with certain solid tumors, including pancreatic, lung and esophageal-gastric cancers. We have

are advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers. Our small-molecule drug candidates target signaling ...

company developing technologies to deliver immune oncology agents to solid tumors in high mortality cancers. Previously, she was Chief Executive Officer

Silenseed

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

for Brain Cancer - Pancan-Protact (Link To Website) - Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - ...

for Brain Cancer - Pancan-Protact (Link To Website) - Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - ...

for Brain Cancer - Pancan-Protact (Link To Website) - Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - ...

- Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - SLSG12D-P2 Solid Tumors Solid tumors appear in over ...

conditions in solid tumors present a strong barrier for effective nano-particle based and systemic drug delivery strategies to treat solid tumors. Moreover

for Brain Cancer - Pancan-Protact (Link To Website) - Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - ...

for Brain Cancer - Pancan-Protact (Link To Website) - Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - ...

for Brain Cancer - Pancan-Protact (Link To Website) - Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - ...

for Brain Cancer - Pancan-Protact (Link To Website) - Science - Solid Tumors - RNA Interference - KRAS - The LODER Platform - Publications - ...

SLSG12D-P2 Day: July 31, 2018 Multistep, effective drug distribution within solid tumors Amotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai, Abraham Domb ...

Oncotarget , Sep 22, 2015 Abstract: The distribution of drugs within solid tumors presents a long-standing barrier for efficient cancer therapies. Tumors

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Gastrointestinal stromal tumor (GIST) Japan Phase III Solid tumors US Phase I Europe Phase I TAS-117 Oral   Solid tumors Japan Phase I TAS-120 Oral FGFR inhibitor  ...

TAS3681 Oral   Prostate cancer US Phase I Europe Phase I TAS0728 Oral   Solid tumors US Phase Ⅰ/Ⅱ Europe Phase Ⅰ/Ⅱ ET-743 Injection Ovarian cancer Japan

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Humanized monoclonal antibody (mAb) therapeutics for the treatment of solid tumors, licensed exclusively from the University of Texas MD Anderson Cancer ...

Therapeutics Small molecule immuno-oncology agents for the treatment of solid tumors and hematologic malignancies. Celmune compounds target an immune cell

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.